Click here for more information about aldesleukin [clinicaltrials_resource:2c4fed5d4ea3516a1763a551d34ee28c]
A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children [clinicaltrials:NCT00000849]A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy [clinicaltrials:NCT00000909]Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 [clinicaltrials:NCT00000948]A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 [clinicaltrials:NCT00000949]A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection [clinicaltrials:NCT00006154]clinicaltrials:NCT00006441Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load [clinicaltrials:NCT00013663]Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection [clinicaltrials:NCT00015652]Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV [clinicaltrials:NCT00056797]
link [clinicaltrials_vocabulary:link]
Click here for more information about aldesleukin [clinicaltrials_resource:2c4fed5d4ea3516a1763a551d34ee28c]
Bio2RDF identifier
2c4fed5d4ea3516a1763a551d34ee28c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2c4fed5d4ea3516a1763a551d34ee28c
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:2c4fed5d4ea3516a1763a551d34ee28c
title
Click here for more information about aldesleukin
@en
type
label
Click here for more informatio ...... fed5d4ea3516a1763a551d34ee28c]
@en